Bing Bai
- Molecular Medicine top 5%
- Molecular Biology
- Infectious Diseases
- Clinical Biochemistry top 5%
- Epidemiology
- Topics
- Antibiotic Resistance in Bacteria (9 papers)Antimicrobial Resistance in Staphylococcus (8 papers)Bacterial Identification and Susceptibility Testing (4 papers)
- Partner nations
- ChinaUnited States
In The Last Decade
Bing Bai
14 papers receiving 321 citations
Peers
Comparison fields: 5 of 65
- Molecular Medicine 145
- Molecular Biology 120
- Infectious Diseases 111
- Clinical Biochemistry 81
- Epidemiology 65
Countries citing papers authored by Bing Bai
This map shows the geographic impact of Bing Bai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bing Bai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bing Bai more than expected).
Fields of papers citing papers by Bing Bai
This network shows the impact of papers produced by Bing Bai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bing Bai. The network helps show where Bing Bai may publish in the future.
Co-authorship network of co-authors of Bing Bai
This figure shows the co-authorship network connecting the top 25 collaborators of Bing Bai. A scholar is included among the top collaborators of Bing Bai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bing Bai. Bing Bai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 4 | |
| 3 | 6 | |
| 4 | 59 | |
| 5 | 9 | |
| 6 | 7 | |
| 7 | 20 | |
| 8 | 45 | |
| 9 | 4 | |
| 10 | 19 | |
| 11 | 18 | |
| 12 | 25 | |
| 13 | 64 | |
| 14 | 41 |
About Bing Bai
Bing Bai is a scholar working on Molecular Medicine, Clinical Biochemistry and Infectious Diseases, having authored 14 papers that have together received 327 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (9 papers), Antimicrobial Resistance in Staphylococcus (8 papers) and Bacterial Identification and Susceptibility Testing (4 papers). The work is most often cited by research in Molecular Medicine (145 citations), Clinical Biochemistry (81 citations) and Applied Microbiology and Biotechnology (21 citations). Bing Bai has collaborated with scholars based in China and United States. Frequent co-authors include Jinxin Zheng, Qiwen Deng, Zhiwei Lin, Guangjian Xu, Zhijian Yu, Zhijian Yu, Xiang Sun, Zhangya Pu, Peiyu Li and Di Qu. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Frontiers in Microbiology and BMC Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.